INVO Fertility (IVF) Change in Receivables (2011 - 2026)
INVO Fertility's (IVF) quarterly Change in Receivables came in at $31124.0 in Q1 2026, up 2556.51% year-on-year from $1171.6 in Q1 2025, and down 2.57% on a QoQ basis from $31945.0 in Q3 2025.
INVO Fertility (IVF) Change in Receivables (2011 - 2026) Analysis & Trends
INVO Fertility (IVF) has 16 years of Change in Receivables data on file, last reported at $31124.0 in Q1 2026.
- On a quarterly basis, Change in Receivables rose 2556.51% year-over-year to $31124.0 in Q1 2026; TTM through Mar 2026 was $130443.0, a 4084.21% increase from a year earlier, with the FY2024 full-year figure at $34331.0, down 45.85% from the prior year.
- Change in Receivables for Q1 2026 stood at $31124.0, down from $31945.0 in the prior quarter.
- Over the last five years, Change in Receivables for IVF reached as high as $80322.0 in Q2 2024 and fell as low as -$82170.0 in Q4 2024.
- Historically, Change in Receivables has averaged $15928.4 across 5 years, with a median of $18698.5 in 2022.
- Across the five-year window, Change in Receivables tumbled 1010.16% in 2023 and soared 20191.19% in 2025, its largest moves.
- Year by year, Change in Receivables stood at $5838.0 in 2022, then soared by 307.14% to $23769.0 in 2023, then slumped by 445.7% to -$82170.0 in 2024, then surged by 138.88% to $31945.0 in 2025, then retreated by 2.57% to $31124.0 in 2026.
- Per Business Quant data, the three most recent Change in Receivables figures were $31124.0 in Q1 2026, $31945.0 in Q3 2025, and $68641.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.89 Bn | 173.59 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 127.82 Bn | 124.94 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 107.49 Bn | 98.27 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 67.24 Bn | 65.78 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 48.02 Bn | 44.34 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 28.25 Bn | 27.14 Bn | 750.30 Mn | -124.60 Mn |
| 7 | GE HealthCare Technologies | 28.17 Bn | 25.89 Bn | 1.98 Bn | -141.00 Mn |
| 8 | Smith & Nephew | 26.72 Bn | 26.14 Bn | - | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.19 Bn | 2.07 Bn | - |
| 10 | INVO Fertility | 1.50 Mn | -3.41 Mn | 732,978.00 | 31,124.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31,124.00 |
| Mar 31, 2026 | 31,124.00 |
| Sep 30, 2025 | 31,945.00 |
| Sep 30, 2025 | 31,945.00 |
| Jun 30, 2025 | 68,641.00 |
| Jun 30, 2025 | 68,641.00 |
| Mar 31, 2025 | -1,267.00 |
| Mar 31, 2025 | -1,267.00 |
| Dec 31, 2024 | -82,170.00 |
| Dec 31, 2024 | -82,170.00 |
| Sep 30, 2024 | -159.00 |
| Sep 30, 2024 | -159.00 |
| Jun 30, 2024 | 80,322.00 |
| Jun 30, 2024 | 80,322.00 |
| Mar 31, 2024 | 36,338.00 |
| Mar 31, 2024 | 36,338.00 |
| Dec 31, 2023 | 23,769.00 |
| Dec 31, 2023 | 23,769.00 |
| Sep 30, 2023 | 41,873.00 |
| Sep 30, 2023 | 41,873.00 |